Mesoblast
MESO
#4332
Rank
A$3.63 B
Marketcap
A$28.22
Share price
3.59%
Change (1 day)
67.60%
Change (1 year)

Mesoblast (MESO) - Cash on Hand

Cash on Hand as of June 2025 : A$0.24 Billion

According to Mesoblast 's latest financial reports the company has A$0.24 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Mesoblast - Cash on Hand chart (from 2012 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-06-30A$93.74 M-11.91%
2023-06-30A$0.10 B22.27%
2022-06-30A$87.03 M-52.17%
2021-06-30A$0.18 B-2.58%
2020-06-30A$0.18 B162.34%
2019-06-30A$71.19 M41.61%
2018-06-30A$50.27 M399.89%
2017-06-30A$10.05 M-65.73%
2016-06-30A$29.34 M6.88%
2015-06-30A$27.45 M576.54%
2014-06-30A$4.05 M-52.95%
2013-06-30A$8.62 M536.55%
2012-06-30A$1.35 M-99.45%
2011-06-30A$0.24 B549.08%
2010-06-30A$37.83 M85.22%
2009-06-30A$20.42 M38.62%
2008-06-30A$14.73 M3.51%
2007-06-30A$14.23 M34.07%
2006-06-30A$10.61 M-46.32%
2005-06-30A$19.78 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NRC Health
NRC
A$3.33 M-98.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
A$0.19 M-99.92% Bahamas